The accuracy of the clinical diagnosis of dementia is severely limited. This project proposes to develop computer-analyzed electroencephalography (CEEG) as a clinical test that will aid in the accurate diagnosis of dementia. It consists of a five-stop research plan. First, ninety geriatric subjects will be examined, divided equally among three groups: those with Alzheimer-type dementia (DAT), multi-infarct dementia (MID), and non-demented normals. All subjects will undergo rigorous clinical evaluations, including mental status and neuropsychological testing, neurological examination, and a battery of relevant laboratory tests. Second, electroencephalograms (EEGs) will be performed on each of the study subjects in the normal resting state and after administration of low-dose secobarbital. Digital EEG data will be collected with an IBM Personal Computer (IBM-PC) attached to the electroencephalograph during the procedures. Third, spectra and coherence functions will be calculated for multiple EEG channels from each subject using the IBM-PC. Fourth, the subjects will be followed to autopsy, wehre neuropathologic diagnoses will be established. Finally, multi-group, stepwise discriminant analysis will be performed under a """"""""training/testing"""""""" paradigm. Using the spectra and coherence variables from half of the subjects in each category, sets of parameters will be selected which correlate most strongly with both clinical and autopsy diagnoses (training portion). The discriminant functions developed from this first analysis will then be used to categorize prospectively the other half of the subjects into both their clinical and autopsy diagnostic categories (testing portion). The results of this discriminant analysis will be analyzed to determine the sensitivity and specificity of CEEG as a diagnostic tool for dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH040705-03
Application #
3379008
Study Section
(PCBB)
Project Start
1986-03-01
Project End
1989-06-30
Budget Start
1988-03-01
Budget End
1989-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Morgan, Melinda L; Cook, Ian A; Rapkin, Andrea J et al. (2007) Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 56:54-60
Hunter, Aimee M; Leuchter, Andrew F; Morgan, Melinda L et al. (2006) Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 163:1426-32
Morgan, Melinda L; Witte, Elise A; Cook, Ian A et al. (2005) Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology 52:71-6
Cook, Ian A; Leuchter, Andrew F; Morgan, Melinda L et al. (2005) Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res 39:461-6
Morgan, Melinda L; Cook, Ian A; Rapkin, Andrea J et al. (2005) Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry 66:774-80
Marie-Mitchell, Ariane; Leuchter, Andrew F; Chou, Chih-Ping et al. (2004) Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res 127:73-84
Stubbeman, William F; Leuchter, Andrew F; Cook, Ian A et al. (2004) Pretreatment neurophysiologic function and ECT response in depression. J ECT 20:142-4
Cook, Ian A; Leuchter, Andrew F; Morgan, Melinda L et al. (2004) Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry 12:190-200
Krell, Heather V; Leuchter, Andrew F; Morgan, Melinda et al. (2004) Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 65:1174-9
Leuchter, Andrew F; Morgan, Melinda; Cook, Ian A et al. (2004) Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) 177:15-22

Showing the most recent 10 out of 44 publications